GO:0014029 neural crest formation: Embryonic Induction, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0014029 neural crest formation describes the embryonic process that establishes the specialized ectodermal region between the neural plate and non-neural ectoderm, from which migratory neural crest cells arise.
Neural crest formation is a transient, tightly timed developmental event that requires precise competence and inductive signals; its disruption causes severe birth defects.
Key transcription factors such as TFAP2A, SOX9, SOX10, PAX3, SNAI1/2, FOXD3, and HAND1/HAND2 orchestrate neural crest specification and differentiation.
Epigenetic regulators, including EZH2 and BRD4, control chromatin accessibility and genome folding necessary for neural crest gene activation.
Altered neural crest formation and neural crest cell behavior contribute to neurocristopathies, including craniofacial malformations, cardiac outflow tract defects, and certain cancers.
Modern research uses single-cell RNA velocity, CRISPR knockout/knock-in models, and multi-omics to dissect the gene regulatory network of neural crest formation.

Description

Neural crest formation (GO:0014029) is the embryonic process that defines a specialized region of ectoderm at the boundary between the neural plate and the adjacent non-neural ectoderm. This region gives rise to neural crest cells, a multipotent, migratory cell population that subsequently contributes to diverse tissues including craniofacial cartilage and bone, peripheral neurons, melanocytes, and cardiac outflow tract structures. Because neural crest formation is a prerequisite for the emergence of these cell types, understanding its molecular control is central to developmental biology and to the study of congenital disease. The process is initiated during gastrulation and neurulation, when inductive interactions between the neural plate, non-neural ectoderm, and underlying mesoderm establish a competent neural crest territory. This competence is followed by the activation of a conserved gene regulatory network that includes transcription factors such as TFAP2A, PAX3, SNAI1/2, FOXD3, and SOX9/SOX10. Disruption of these regulators impairs neural crest formation and causes neurocristopathies, a broad class of disorders affecting craniofacial, cardiac, and peripheral nervous system development. Consequently, GO:0014029 is a focal point for researchers using CRISPR-based models, single-cell genomics, and epigenomic profiling to link genotype to developmental phenotype.

neural crest formation At A Glance

GO ID GO:0014029
GO term neural crest formation
Ontology biological_process
Synonym None listed in QuickGO
Major function Specification and formation of the neural crest territory at the neural plate border, giving rise to migratory neural crest cells
Developmental timing Occurs during gastrulation and neurulation, before neural crest cell delamination and migration
Key regulators TFAP2A, PAX3, SNAI1/2, FOXD3, SOX9, SOX10, HAND1/HAND2, EZH2, BRD4
Associated diseases Neurocristopathies including craniofacial malformations, cardiac outflow tract defects, and neural crest-derived tumors
Research methods Single-cell RNA velocity, CRISPR KO/knock-in, epigenomics, lineage tracing

What Is GO:0014029?

GO:0014029 neural crest formation is defined as the formation of the specialized region of ectoderm between the neural ectoderm (neural plate) and non-neural ectoderm. This region gives rise to neural crest cells that migrate away as neural tube formation proceeds. In practical terms, it covers the early embryonic events that specify and delimit the neural crest territory, before the cells undergo epithelial-to-mesenchymal transition and migration.

Why Is neural crest formation Important in Cell Biology?

Neural crest formation is important because it establishes the progenitor pool for a wide range of cell types and because its failure leads to some of the most common human congenital anomalies. The process sits at the intersection of embryonic induction, gene regulatory networks, and epigenetic control, making it a paradigm for studying how cell fate is specified. Moreover, neural crest-derived cells contribute to cancers such as melanoma and neuroblastoma, so understanding neural crest formation informs both developmental biology and oncology.
Defines the neural crest territory, a transient embryonic structure essential for craniofacial, cardiac, and peripheral nervous system development.
Disruption causes neurocristopathies such as CHARGE syndrome and Waardenburg syndrome.
Provides a model for studying inductive signaling and competence during early embryogenesis.
Involves a conserved gene regulatory network that is reused in neural crest-derived tumors.
Epigenetic regulators such as EZH2 and BRD4 are required for neural crest formation and downstream differentiation.
Single-cell RNA velocity can reconstruct neural crest lineage trajectories in vivo.
CRISPR-based knockout and knock-in models enable causal testing of candidate neural crest genes.
Neural crest formation is a target for understanding birth defects and for regenerative medicine approaches.

What Happens During neural crest formation?

Induction and competence at the neural plate border
In simple terms: The embryo first makes a strip of cells competent to become neural crest, then signals tell them to take that fate.
Neural crest formation begins with the establishment of a competent territory at the neural plate border, a region between the neural plate and non-neural ectoderm. Inductive signals from adjacent tissues, including the neural plate and underlying mesoderm, confer this competence during gastrulation. The timing and competence of neural crest formation are tightly regulated, and only cells receiving the appropriate signals within a specific window will form neural crest. This step is a prerequisite for all subsequent neural crest cell behaviors.
Activation of the neural crest gene regulatory network
In simple terms: A set of master control genes switches on and locks in the neural crest identity.
Once competence is established, a conserved gene regulatory network is activated. Transcription factors such as TFAP2A, PAX3, SNAI1/2, FOXD3, and SOX9/SOX10 are expressed in the neural crest territory and regulate downstream targets. Combinatorial transcriptional interactions, for example between HAND1 and HAND2, are required for cardiac neural crest development. This network reinforces neural crest identity and represses alternative fates.
Epigenetic and chromatin remodeling
In simple terms: The DNA packaging must be opened so the neural crest genes can be read.
Epigenetic regulation is essential for neural crest formation. EZH2, a component of the Polycomb repressive complex 2, is required for neural crest-derived cartilage and bone formation. BRD4, a chromatin reader, orchestrates genome folding to promote neural crest differentiation. These findings indicate that chromatin architecture and histone modifications are integral to the neural crest gene regulatory network.
Metabolic and signaling inputs
In simple terms: The cell's metabolism and external signals influence whether neural crest forms correctly.
Neural crest metabolism is at the crossroads of development and disease, with metabolic pathways influencing neural crest formation and differentiation. Signaling inputs, including those from the surrounding tissues, modulate the gene regulatory network. Disruption of these inputs can alter neural crest formation and contribute to neurocristopathies.
Transition to migration and differentiation
In simple terms: After the neural crest is formed, its cells leave and become many different tissues.
Following formation, neural crest cells undergo epithelial-to-mesenchymal transition and migrate away as neural tube formation proceeds. They subsequently differentiate into diverse derivatives, including craniofacial cartilage and bone, peripheral neurons, and melanocytes. This transition is a hallmark of neural crest formation and is required for the proper development of multiple organ systems.

Key Genes Involved in GO:0014029 neural crest formation

The following genes and proteins are central to neural crest formation and its regulation, as supported by the cited literature.
GeneMajor RoleResearch Relevance
TFAP2ATranscription factor in neural crest specificationMutated in branchio-oculo-facial syndrome; key node in gene regulatory network
PAX3Neural crest induction and melanocyte developmentAssociated with Waardenburg syndrome; target for CRISPR knockout studies
SNAI1Promotes epithelial-to-mesenchymal transitionEssential for neural crest delamination; studied in chick and mouse models
SNAI2Neural crest migration and survivalDefects cause piebaldism; used in lineage tracing
FOXD3Maintains neural crest progenitor stateRepresses differentiation; studied in pluripotent stem cell models
SOX9Neural crest-derived cartilage and bone formationRequired for craniofacial skeleton; EZH2 interacts with this pathway
SOX10Neural crest and melanocyte specificationMutated in Waardenburg syndrome; key marker for neural crest cells
HAND1Cardiac neural crest transcription factorCombinatorial interaction with HAND2 in heart formation
HAND2Cardiac neural crest transcription factorDimerizes with HAND1; required for outflow tract development
EZH2Histone methyltransferase; epigenetic repressionRequired for neural crest-derived cartilage and bone formation
BRD4Chromatin reader; genome foldingPromotes neural crest differentiation; target for BET inhibitors
CHD7Chromatin remodelingMutated in CHARGE syndrome, a neurocristopathy
TWIST1Neural crest migration and craniofacial developmentAssociated with Saethre-Chotzen syndrome
EDNRBNeural crest-derived melanocyte and enteric neuron developmentMutated in Hirschsprung disease
RETEnteric neural crest developmentMutated in Hirschsprung disease and MEN2
MITFMelanocyte differentiationMaster regulator of melanocytes; melanoma relevance
CDH1Cell adhesion during neural crest formationLoss promotes EMT; studied in CRISPR models

How Is neural crest formation Regulated?

Neural crest formation is regulated by a combination of inductive signals, transcription factor networks, and epigenetic modifiers. The timing and competence of neural crest formation are controlled by signals from adjacent tissues during gastrulation. Epigenetic regulators such as EZH2 and BRD4 modulate chromatin accessibility and genome folding to permit neural crest gene expression. Metabolic pathways also influence neural crest formation, linking cellular energetics to developmental decisions. These layers of regulation ensure that neural crest formation occurs only in the correct spatial and temporal window.

neural crest formation and Human Disease

GeneDisease / BiologyPotential Experimental Model
CHD7CHARGE syndromeKnockout mouse or iPSC-derived neural crest cells
PAX3Waardenburg syndromePoint mutation knock-in in cell lines
SOX10Waardenburg syndrome, Hirschsprung diseaseKnockout and rescue in neural crest stem cells
HAND2Cardiac outflow tract defectsCardiac neural crest-specific knockout
EZH2Craniofacial and skeletal defectsConditional knockout in neural crest lineage
Neurocristopathies and craniofacial malformations
Disruption of neural crest formation causes neurocristopathies, a group of disorders affecting tissues derived from the neural crest. CHARGE syndrome, caused by mutations in CHD7, is a neurocristopathy with craniofacial and cardiac defects. Waardenburg syndrome, associated with PAX3 and SOX10 mutations, affects melanocytes and hearing. These conditions highlight the clinical importance of neural crest formation.
Cardiac outflow tract defects
Cardiac neural crest cells contribute to the outflow tract and septation of the heart. Combinatorial interactions between HAND1 and HAND2 are required for cardiac neural crest development, and their disruption leads to heart malformations. Thus, neural crest formation is directly linked to congenital heart disease.
Neural crest-derived cancers
Neural crest cells give rise to melanoma, neuroblastoma, and other tumors. Metabolic reprogramming in neural crest cells is at the crossroads of development and disease, and understanding neural crest formation may reveal therapeutic vulnerabilities. Epigenetic regulators such as BRD4 are also implicated in cancer, linking neural crest biology to oncology.

From neural crest formation-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of a candidate gene impair neural crest formation?CRISPR knockout in human embryonic stem cells or iPSCs
Does a specific point mutation cause neurocristopathy?CRISPR point mutation knock-in in cell lines
Can a wild-type gene rescue a neural crest defect?Knock-in of tagged or wild-type allele
Where and when is a neural crest gene expressed?Tagged knock-in reporter (e.g., GFP)
Does overexpression of a gene expand neural crest territory?Inducible overexpression in zebrafish or chick embryos
What is the epigenetic landscape during neural crest formation?CRISPR knockout of EZH2 or BRD4 followed by ATAC-seq

How to Study the neural crest formation Process

MethodWhat It MeasuresTypical Application
Single-cell RNA velocityDirectionality of differentiationReconstructing neural crest lineage trajectories
ATAC-seqChromatin accessibilityIdentifying regulatory elements active during neural crest formation
ChIP-seqProtein-DNA bindingMapping EZH2 or BRD4 occupancy
CRISPR knockoutGene function lossTesting necessity of candidate genes
CRISPR knock-inTagged or mutant allele expressionVisualizing or mutating endogenous genes
RNA-seqTranscriptome changesComparing wild-type and mutant neural crest cells
Lineage tracingCell fate and migrationFollowing neural crest derivatives in vivo
MetabolomicsMetabolite levelsLinking metabolism to neural crest formation
Single-cell RNA velocity
Single-cell RNA velocity uses spliced and unspliced mRNA ratios to infer developmental trajectories, including neural crest formation and differentiation. This method can reconstruct the lineage from neural plate border to migratory neural crest cells.
Epigenomic profiling
ATAC-seq and ChIP-seq for histone modifications reveal chromatin accessibility and enhancer usage during neural crest formation. BRD4 and EZH2 occupancy can be mapped to understand genome folding and repression.
CRISPR-based functional genomics
CRISPR knockout and knock-in models allow causal testing of genes in neural crest formation. Pooled screens can identify novel regulators, while single-cell readouts link genotype to phenotype.
Lineage tracing and imaging
Genetic lineage tracing with fluorescent reporters visualizes neural crest cell migration and differentiation in vivo. Live imaging in zebrafish or chick embryos captures the dynamics of neural crest formation.

How CRISPR Can Be Used to Study GO:0014029 neural crest formation

Knockout

CRISPR knockout of neural crest genes such as TFAP2A, PAX3, or SOX10 in human pluripotent stem cells can reveal their requirement for neural crest formation. Knockout models are used to test necessity and to identify downstream targets.

Point Mutation

Point mutation knock-in can model patient-specific variants in genes like CHD7 or PAX3 to study neurocristopathies. This approach distinguishes pathogenic variants from benign polymorphisms.

Knock-in

Knock-in of reporter tags (e.g., GFP) or rescue constructs allows visualization and functional rescue of neural crest genes. Tagged knock-in lines are valuable for lineage tracing and protein localization.

Overexpression

Overexpression of neural crest regulators such as SNAI1 or FOXD3 can expand the neural crest territory or block differentiation, providing gain-of-function insights. Inducible systems allow temporal control of overexpression.

How EDITGENE Supports neural crest formation Research

Researchers studying neural crest formation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes implicated in neural crest formation and neurocristopathies.
Contact EDITGENE today to design your custom CRISPR model for neural crest formation research.

Frequently Asked Questions About neural crest formation

GO:0014029 is a Gene Ontology biological process term describing the formation of the specialized ectoderm between the neural plate and non-neural ectoderm, which gives rise to migratory neural crest cells.
Key genes include TFAP2A, PAX3, SNAI1/2, FOXD3, SOX9, SOX10, HAND1, HAND2, EZH2, and BRD4, as supported by developmental studies.
It establishes progenitors for craniofacial cartilage and bone, peripheral neurons, melanocytes, and cardiac structures; its disruption causes neurocristopathies.
Neurocristopathies such as CHARGE syndrome, Waardenburg syndrome, Hirschsprung disease, and cardiac outflow tract defects.
It is regulated by inductive signals, a conserved transcription factor network, and epigenetic modifiers like EZH2 and BRD4.
Single-cell RNA velocity, ATAC-seq, ChIP-seq, CRISPR knockout/knock-in, lineage tracing, and metabolomics.
Yes, CRISPR knockout and knock-in in pluripotent stem cells enable causal testing of neural crest genes.
EZH2 is required for neural crest-derived cartilage and bone formation, acting as an epigenetic regulator.
BRD4 orchestrates genome folding to promote neural crest differentiation, and its loss impairs this process.
Neural crest cells give rise to craniofacial cartilage and bone, peripheral neurons, melanocytes, and cardiac outflow tract components.

Conclusion

GO:0014029 neural crest formation is a foundational developmental process that specifies the neural crest territory and enables the formation of diverse cell lineages. Its molecular control involves a conserved gene regulatory network, epigenetic regulators, and metabolic inputs, and its disruption underlies numerous congenital disorders and cancers. Continued research using CRISPR models and single-cell technologies will further clarify how this process is orchestrated and how it can be targeted therapeutically.

References

  1. 1. La Manno G et al.. 2018. RNA velocity of single cells.. Nature 560(7719):494-498 PMID: 30089906
  2. 2. Pauli S et al.. 2017. CHARGEd with neural crest defects.. Am J Med Genet C Semin Med Genet 175(4):478-486 PMID: 29082625
  3. 3. Linares-Saldana R et al.. 2021. BRD4 orchestrates genome folding to promote neural crest differentiation.. Nat Genet 53(10):1480-1492 PMID: 34611363
  4. 4. Firulli AB et al.. 2004. Combinatorial transcriptional interaction within the cardiac neural crest: a pair of HANDs in heart formation.. Birth Defects Res C Embryo Today 72(2):151-61 PMID: 15269889
  5. 5. Basch ML et al.. 2000. Timing and competence of neural crest formation.. Dev Neurosci 22(3):217-27 PMID: 10894985
  6. 6. Bhattacharya D et al.. 2021. Neural crest metabolism: At the crossroads of development and disease.. Dev Biol 475:245-255 PMID: 33548210
  7. 7. Schwarz D et al.. 2014. Ezh2 is required for neural crest-derived cartilage and bone formation.. Development 141(4):867-77 PMID: 24496623
  8. 8. Hu N et al.. 2014. Epigenetic regulation in neural crest development.. Dev Biol 396(2):159-68 PMID: 25446277
Contact Us
*
*
*
*
How did you hear about us: